Professor Jean-Pascal Machiels Head of the Department of Medical Oncology at the Cliniques Universitaires Sain-Luc, Brussels, presented results of the KEYNOTE-412 trial at this years ESMO Congress. This was a phase 3 study evaluating pembrolizmab with chemoradiation therapy in locally advanced head and neck squamosus cell carcinoma. 

Video: https://congressreport.eu/scientific-contents/interview:primary-results-phase-3-keynote-412-study

Professor John Haanen from the Netherlands Cancer Institute presented the first randomized phase 3 trial on treatment with tumor-infiltrating lymphocytes vs. ipilimumab for advanced melanoma at this years ESMO Congress. 

Video: https://congressreport.eu/scientific-contents/interview:treatment-tumor-infiltrating-lymphocytes-versus-ipilimumab-advanced-melanoma

Professor Ambarish Pandey presented the results a randomised clinical trial about the effect of liraglutide on muscle fat infiltration in overweight or obesity adults at the recent EASD 2022 Congress. We asked him about the result.

Video: https://congressreport.eu/scientific-contents/interview:effect-liraglutide-muscle-fat-infiltration-adults-overweight-or-obesity

Siow Ming Lee, Professor of Medical Oncology at University College London, presented the results of the IPSOS trial at the ESMO 2022 Congress.

This was a phase 3 study evaluating first-line atezolizumab vs. single agent chemotherapy in NSCLC patients not eligible for a platinum-based regimen.

Video: https://congressreport.eu/scientific-contents/interview:ipsos-trial

Professor Charlotte Suppli Ulrik took part in a very interesting session at this years ERS congress on how to maximize patients outcome in asthma and COPD. We asked her about the topic.

Video: https://congressreport.eu/scientific-contents/interview:choices-asthma-and-copd-care-how-maximize-outcomes-patients

Dr John Coghlan going to share his insights with us on evidence - based treatment decisions in pulmonary arterial hypertension.

Video: https://congressreport.eu/scientific-contents/interview:fresh-look-pulmonary-hypertension-practical-takeaways-patient-management

Professor Remo Furtado had an important presentation on the Influenza Vaccine among patients with Acute Coronary Syndromes at this year’s ESC Congress. He is going to share his insights with us on the topic.

Video: https://congressreport.eu/scientific-contents/interview:influenza-vaccine-among-patients-acute-coronary-syndromes-vip-acs-trial

Professor Ingrid Pabinger held a presentation on extended anticoagulation in venous thromboembolism at the recent ESC Congress in Barcelona. We asked her to share the most important conclusions with us.

Video: https://congressreport.eu/scientific-contents/interview:facing-anticoagulation-dilemmas-venous-thromboembolism

Professor Dan Atar had an important presentation on the importance of optimal RAASi therapy in heart failure at this year’s ESC Congress. He is going to share his insights with us on the topic.

Video: https://congressreport.eu/scientific-contents/interview:importance-optimal-raasi-therapy-heart-failure

Professor Athanasios J. Manolis chaired a very eye-opening session on how to improve care in patients with chronic coronry syndrome at this years ESC Congress. We asked him to share his insights with us on the topic.

Video: https://congressreport.eu/scientific-contents/interview:chronic-coronary-syndrome-re-thinking-treatment-management-and-outcome-priorities